Delivery Order SPE2DE24D0026-SPE2D626F172B
- Not listed
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to Henry Schein, Inc.'s USDG Federal Division on August 21, 2025, for the supply of Lidocaine HCL 2% in 50-unit quantities. The contract, valued at $2,927.20, utilizes a fixed-price structure with economic price adjustment provisions and carries an ultimate completion date of September 5, 2025. This delivery order was issued without a set-aside designation, reflecting full and open competition. The place of performance...
- On October 23, 2025, the Defense Logistics Agency's Medical Supply Chain organization awarded a delivery order valued at $2,846.89 to Henry Schein, Inc. for the supply of Lidocaine HCL 2% in 50-unit quantities. The contract is structured as a fixed-price agreement with economic price adjustment provisions and carries an ultimate completion date of November 6, 2025. This delivery order was issued without a set-aside designation, utilizing full and open competition procurement methodologies....
- Henry Schein, Inc.'s USDG Federal Division was awarded a delivery order on September 9, 2025, for the supply of Lidocaine HCL 2% in 50-unit quantities to the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment carries a ceiling value of $3,497.26 and an ultimate completion date of September 23, 2025. The contract utilizes no set-aside designation and represents performance to be fulfilled at the contractor's location in Huntington...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to Henry Schein, Inc.'s USDG Federal Division on August 27, 2025, for the supply of Lidocaine Cartridge 2% with Epinephrine. This fixed-price delivery order, valued at $1,592.44, represents a task order under Henry Schein's existing Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical Electronic Catalog (ECAT) program—a $30 million contract running through April 2030. The award was...
- The Defense Logistics Agency's Medical Supply Chain organization awarded a $1.83K delivery order to Henry Schein, Inc. (USDG Federal Division) on November 7, 2025, for the supply of Lidocaine Cartridge 2% with Epinephrine. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by November 24, 2025, and will be performed at Henry Schein's facility in Huntington Station, New York. No set-aside designation was utilized, indicating the award was made...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to Henry Schein, Inc.'s USDG Federal Division on September 8, 2025, for the supply of Lidocaine Cartridge 2% with Epinephrine. This fixed-price contract with economic price adjustment carries a ceiling value of $2,020.38 and an ultimate completion date of September 11, 2025. The contract was awarded without a set-aside designation through full and open competition. Performance will be executed at Henry Schein's...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to Henry Schein, Inc.'s USDG Federal Division for the supply of Lidocaine Cartridge 2% with Epinephrine. This fixed-price delivery order, valued at $2,762.90, was awarded on July 30, 2025, with an ultimate completion date of August 4, 2025. The contract utilizes economic price adjustment provisions and does not include a set-aside designation. Performance will take place at Henry Schein's facility in Huntington Station,...
- The Defense Logistics Agency Troop Support Medical awarded Henry Schein, Inc. Enterprise Health / Federal Sales Division a $120,640 delivery order to supply 50 boxes of 2% lidocaine hydrochloride. The order is a fixed price contract with economic price adjustment terms. Performance will take place at Henry Schein's facility in Huntington Station, New York, spanning from September 14th to September 27th, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency...
- This is a $3,178.69 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Henry Schein, Inc., a Fortune 500 medical and dental supply distributor, for the delivery of lidocaine HCL 2% in 50-count units. The contract has an ultimate completion date of July 23, 2025 and is not set aside for any specific small business designation. Henry Schein, Inc. operates under its Usdg Federal Division to serve various government healthcare customers, including the Department...
- This is a delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Henry Schein, Inc., a global distributor of medical and dental supplies. The award, valued at $4,663.85, is for the delivery of lidocaine hydrochloride 2% in 50-count packages. The delivery order is a fixed-price contract with economic price adjustment, with a completion date of November 21, 2024. The contract does not have a set-aside designation, indicating it was competed on a full...
- SPE2DE24D0026Indefinite Delivery Contract
- SPE2DE24D0026-SPE2D626F172BDelivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to Henry Schein, Inc.'s USDG Federal Division on November 14, 2025, for the supply of Lidocaine HCL 2% in 50-unit quantities, with a contract ceiling value of $2,445.55. This fixed-price delivery order with economic price adjustment was issued without set-aside designation under full and open competition. The work will be performed at Henry Schein's facility in Huntington Station, New York, with an ultimate completion date of December 1, 2025. This delivery order represents one of numerous procurement actions executed under Henry Schein's broader $30 million Indefinite Delivery Contract (No. 4610117412) with DLA Troop Support Medical, which was awarded on April 23, 2025, and authorizes the supply of laboratory equipment, medical consumables, and related items to support Department of Defense and other federal healthcare operations through the Electronic Catalog program. Henry Schein, a Fortune 500 global medical and dental supply distributor, has established itself as a critical federal supplier serving multiple agencies including the Department of Defense, Veterans Affairs, and the Federal Bureau of Prisons network. The company's extensive federal contract portfolio demonstrates expertise in supplying diverse medical and pharmaceutical products, including surgical supplies, diagnostic equipment, anesthesia products, and medical consumables. The Lidocaine HCL supply under this delivery order supports pharmaceutical inventory requirements for federal medical facilities and military medical operations, aligning with the company's established role as a primary vendor for healthcare product distribution across the federal sector.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 11/14/25 |